5th Maruzza International Congress
5th Maruzza International Congress

Delegate Abstract Guidelines

A large part of the congress programme is abstract-driven. We encourage work that introduces new ideas and/or concepts; new research findings and advances to the field of Paediatric Palliative Care, as well as analysis of both success and failure. Case studies will be also considered.
Abstracts must be submitted using the electronic abstract form  and can be denoted for either oral or poster presentation. All accepted abstracts will be published in the virtual abstract book, which will be downloadable on the Congress website. All posters will be displayed in the poster exhibition area.

Abstract Deadlines

Submission deadline: 6th March 2022

Final acceptance notification: 27th March 2022

Presenting Author registration deadline: 10th April 2022

Abstract Should Clearly State

Background-context-aims: indicate the purpose and objective of the research, the hypothesis that was tested or a description of the problem discussed.

Methods: describe the setting/location for the study, study design, study population, ethical considerations, data collection and methods of statistical analysis.
Results: present as clearly and detailed as possible the findings/outcome of the study, with specific results in summarized form.
Conclusions: briefly discuss the data and main outcome of the study as well as its possible limitations. Emphasize the implications of the results and their significance for the treatment, care and/or support of children and their families affected by life-limiting or life-threatening illness.

Presentation Type

Authors must indicate their preference for oral/poster presentation or poster presentation only.

Rules For Submission

The Presenting Author is expected to attend the conference and display the poster and/or manage the oral presentation.

Please kindly note that the submission of an abstract does not replace the registration to the congress. The Presenting Author must register by the 10th April 2022 for the abstract to appear in the final program and the proceedings. Failure to register before the 10th April 2022 will result in automatic withdrawal of the abstract from the conference proceedings and programme. If the scientific committee does not accept the abstract, the delegate’s fee could be reimbursed. It is the author’s responsibility to submit a correct abstract. Before submitting the abstract, the author(s) will be required to confirm the following:

1. I accept that the final decision about rejection, type of presentation and the composition of the programme will be made by the Scientific Committee.
2. I confirm that I previewed this abstract and that all information is correct. I accept that the content of this abstract cannot be modified or corrected after final submission and I am aware that it will be published exactly as submitted.
3. Submission of your abstract constitutes your consent to publication (e.g. conference website, programs, other promotions, etc.)
4. I herewith confirm that the contact details saved in this system are those of the corresponding author, who will be notified about the status of the abstract. The corresponding author is responsible for informing the other authors about the status of the abstract.
5. I assure that the abstract has not yet been published in another international conference, and that its publication does not breach any author rights.
6. I am aware of that after acceptance through the scientific committee my abstract will be included in the scientific programme and appear in the abstract book, if the presenting author has registered at the  Congress beforehand.
7. Consent in accordance with articles 7, 23, 42 and 43 of the Italian Privacy Law 196/03. I am acquainted with the information according to the Italian Privacy Law and I give my consent to the treatment and communication of my personal data solely in relation to or instrumental to the activities within the aims and objectives of the Congress, as indicated. I am aware that, without my consent, registration cannot be completed.
8. I confirm that all authors are aware of the content of the abstract and authorise its submission.

Abstract Preparation

Abstracts should meet the following criteria:
The abstract text cannot exceed 2000 characters (including spaces, excluding title and authors).
Abstracts must be written in English, explained abbreviations may be used.
The abstract text must not contain any information about the presenters or institutions involved, in order to facilitate the blind review process.
The number of authors should not exceed eight.
References are not required. If supplied, they are included in the character count.
Generic drug names should be preferred. The use of trade names is discouraged, and should only be used when necessary.
The main source of funding of a study is required to be indicated at the end of the abstract
The abstract may not have been published at a previous International congress.
The abstract may not have been published previously in any International or national journal.

Handling Procedures

Abstracts may only be submitted using the electronic abstract form.
Once the electronic submission is concluded the corresponding author will receive an automatic confirmation by email with an abstract number to which he/she will need to refer for any inquiries.
After the reviewing process, the Scientific Committee will allocate the accepted abstracts to the poster presentation and/or oral presentations, all corresponding authors will be notified by email of the decision of the Scientific Committee he/she will be responsible for informing the other authors about the status of the abstract.

Abstract Review

The review will be carried out according to the following criteria:
Background-Context-Aims (Reference to relevant knowledge base, Rationale of the study, Relevance of hypothesis, Clarity of stated aims).
Methods (Sampling criteria, Data collection, Analytical strategy, Statistical methods).
Results (Clarity of data presentation, Statistical Power)
Conclusions (Interpretation of the results, Conclusions supported by the data presented, Relevance to paediatric palliative care)
Originality of Research (Is new data being presented? Are new concepts being presented? Stringency or novelty of arguments when repeating previous work).
Relevance to Paediatric Palliative Care (The abstract must demonstrate relevance to paediatric palliative care practice, policy or research, or make a contribution to a significant theoretical or methodological issue).

Posters And Oral Presentation

The Scientific Committee makes the final selection of abstracts to be developed as posters or oral presentations.
Please notice the following when preparing your poster:
Poster dimensions should not exceed 100×200 cm – width/height (common poster size is about 90×120 cm)
State the title and the authors at the top of your poster in easily readable bold letters
Indicate the presenting author if different from the first author.
The text and the illustrations should be readable from a distance of 2 meters
Please notice the following when preparing for an oral presentation: The authors of the posters selected for oral presentations are requested to attend the presentation sessions. Oral presentation should be no more than 10 minutes long (a maximum of 10 slides) . For questions and transition to the next speaker, 5 minutes are foreseen. The talks are scheduled every 15 minutes.

We will accept presentation files in PowerPoint only.

You must use common system fonts.
You must transfer your presentation file onto one of our computers (the use of your laptops is not allowed).

The most reliable method for transferring your file is a USB Flash Drive.
All rooms are equipped with computers with Office, projectors and presentation clickers.